中
Home
About TUL
Group Introduction
Executive Directors
Subsidiaries
Contact Us
Innovation in R&D
R&D Pipeline
R&D Platform
R&D Updates
News
TUL Highlights
Product Center
Finished Products
Comprehensive Health Products
APIs and Intermediates
Animal protection products
Empty capsule
Medical device
Cosmetic Peptide Series
Sustainability
Enhancing Governance
Normalizing Healthiness
Brand Building
People-Oriented
Green Development
ESG Reports
ESG News
Investor Relations
News
TUL Highlights
TUL Makes Its Debut at CPHI Middle East
Date：2024-12-13
Views：392
From December 10 to 12, 2024, CPHI Middle East was held in Riyadh with grand opening. TUL made its debut at this exhibition, establishing close ties with clients in Saudi Arabia and other Middle Eastern countries.
Previous：
First batch in Guangdong! Three varieties including TUL’s liraglutide injection were approved as pilot products for segmented production
Next：
TUL Receives the Title of “Most Valuable Pharmaceutical and Medical Company”
WeChat
Official
Account
To Top
粤公网安备44040402000348号